Skip to content

Effect of acupressure on fatigue and anxiety in the patients with cancer

Effect of acupressure on fatigue and anxiety in the patients with cancer: single-blind randomized clinical trial in three groups (intervention, placebo and control)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201301219759N2
Enrollment
90
Registered
2013-02-12
Start date
2013-02-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Cancer. Condition 3: Cancer. Condition 4: Cancer. Condition 5: Cancer. Condition 6: Cancer. Condition 7: Fatigue. Condition 8: Cancer. Other mixed anxiety disorders Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue Malignant neoplasms of ill-defined, secondary and unspecified sites Malignant neoplasms of independent (primary) multiple sites In situ neoplasms Neoplasms of uncert

Interventions

Intervention 1: Intervention group: in the intervention group acupressure will be conducted on the fifteen correct acupoints in ten sessions for half an hour during two weeks. Intervention 2: Placebo
Treatment - Other
Intervention group: in the intervention group acupressure will be conducted on the fifteen correct acupoints in ten sessions for half an hour during two weeks.
Placebo group: in the placebo group acupressure will be conducted on the fifteen sham acupoints close to correct acupoints in the ten sessions for half an hour during two weeks.

Sponsors

Vice-Chancellor of Research and Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: The patients with cancer in hematology unit will be included in the study with following criteria: (a) II, III, and IV stages of cancer; (b) consciousness; (c) lack of amputation or ulcer at the acupoints; (d) lack of sever heart failure; (e) lack of hypothyroidism; (f) lack of coagulant disorders. The patients will be excluded from the study with the following criteria: (a) hemoglobin less than nine gram per deciliter; (b) platelet less than 50000 per microliter; (c) pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: Before intervention, before the sixth session of intervention and after the tenth session of intervention. Method of measurement: Brief Fatigue Inventory questionnaire.;Anxiety. Timepoint: Before intervention, before the sixth session of intervention and after the tenth session of intervention. Method of measurement: Spielberger anxiety questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Bikmoradi

Department of Medical Surgical Nursing

bikmoradi@umsha.ac.ir; abeikmoradi@yahoo.com+98 81 1838 0439

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026